| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-14 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-10 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-09 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-07 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-07 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |